Literature DB >> 14572906

The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants.

Keisuke Nakajou1, Hiroshi Watanabe, Ulrich Kragh-Hansen, Toru Maruyama, Masaki Otagiri.   

Abstract

Recombinant wild-type human serum albumin (rHSA), the single-residue mutants K199A, K439A and K525A and the triple-residue mutant K199A/K439A/K525A were produced using a yeast expression system. Portions of the rHSA were glycated to different degrees (2.5-250 mM D-glucose). As detected by far-UV and near-UV CD, intrinsic tryptophan-fluorescence and probed by 1,1'-bis(4-anilino)naphthalene-5,5-disulfonic acid, the single-residue mutations had no effect on albumin conformation, whereas the triple-residue mutation and glycation caused conformational changes. The triple-residue mutation and glycation had comparable increased effects on high-affinity binding of warfarin (site I), but decreased effects on high-affinity binding of dansylsarcosine (site II) and the esterase-like activity of albumin. The relation between plasma half-lives in rats were found to be glycated rHSA (50 mM glucose)<triple-residue mutated rHSA<rHSA. The opposite trend was found for liver and kidney uptakes in mice. Even though the functional and the in vivo properties of rHSA could be effected differently by the minor conformational changes caused by the triple-residue mutation and glycation, the present findings indicate that the effect of glycation can be partly explained by blockage of the positive charges of lysine at positions 199, 439 and 525.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572906     DOI: 10.1016/j.bbagen.2003.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Authors:  K S Joseph; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-05-06       Impact factor: 3.935

2.  Comparison of modification sites formed on human serum albumin at various stages of glycation.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-10-27       Impact factor: 3.786

Review 3.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

4.  Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.

Authors:  Abby J Jackson; Jeanethe Anguizola; Erika L Pfaunmiller; David S Hage
Journal:  Anal Bioanal Chem       Date:  2013-05-09       Impact factor: 4.142

5.  Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.

Authors:  Ryan Matsuda; Zhao Li; Xiwei Zheng; David S Hage
Journal:  J Chromatogr A       Date:  2015-07-06       Impact factor: 4.759

6.  Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Donald Jobe; Jared Beyersdorf; David S Hage
Journal:  J Chromatogr A       Date:  2015-09-09       Impact factor: 4.759

7.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

8.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

9.  Binding of lipoic acid induces conformational change and appearance of a new binding site in methylglyoxal modified serum albumin.

Authors:  George Suji; Santosh A Khedkar; Sreelekha K Singh; Nand Kishore; Evans C Coutinho; Vikrant M Bhor; S Sivakami
Journal:  Protein J       Date:  2008-06       Impact factor: 2.371

10.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.